Research Article
Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer
Table 4
Correlation of TGF-β subtypes with OS and PFS in ovarian cancer patients treated with different chemotherapy strategies.
| TGF-β subtypes | Chemotherapy | Cases | OS | value | Cases | PFS | value | HR (95% CI) | HR (95% CI) |
| TGF-β1 | Platin | 1409 | 1.09 (0.95–1.26) | 0.23 | 1259 | 1.08 (0.94–1.24) | 0.27 | Taxol | 793 | 0.86 (0.69–1.07) | 0.18 | 715 | 0.85 (0.69–1.03) | 0.094 | Platin+Taxol | 776 | 0.88 (0.71–1.11) | 0.28 | 698 | 0.86 (0.70–1.05) | 0.13 |
| TGF-β2 | Platin | 1409 | 1.20 (1.04–1.38) | 0.0120 | 1259 | 1.46 (1.26–1.67) | 0.001 | Taxol | 793 | 1.27 (1.03–1.56) | 0.025 | 715 | 1.43 (1.18–1.72) | 0.0002 | Platin+Taxol | 776 | 1.27 (1.03–1.57) | 0.024 | 698 | 1.44 (1.20–1.74) | 0.0001 |
| TGF-β3 | Platin | 1409 | 1.20 (1.03–1.39) | 0.016 | 1259 | 0.83 (0.72–0.96) | 0.014 | Taxol | 793 | 1.18 (0.97–1.43) | 0.099 | 715 | 1.31 (1.10–1.55) | 0.0024 | Platin+Taxol | 776 | 1.19 (0.98–1.44) | 0.085 | 698 | 1.31 (1.10–1.57) | 0.0021 |
| TGF-β4 | Platin | 1409 | 1.11 (0.95–1.29) | 0.19 | 1259 | 0.85 (0.75–0.98) | 0.02 | Taxol | 793 | 1.13 (0.92–1.38) | 0.24 | 715 | 1.15 (0.97–1.36) | 0.12 | Platin+Taxol | 776 | 1.16 (0.95–1.42) | 0.16 | 698 | 1.17 (0.99–1.4) | 0.07 |
|
|
|